← SynDRA
GSK2981278
SynDRA canonical compound SYN0039338 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
| Primary target(s) | RORC |
| Mechanism of action | ROR modulator |
All known targets
Mechanisms of action (all sources)
- RORC INVERSE AGONIST
- ROR modulator
- RORC AGONIST
Cross-references
Synonyms
- Gsk-2981278
- Ror gama modulator 1
- ROR gama modulator 1
- UNII-L49V5G013I
- L49V5G013I
- N-(4-ethylphenyl)-3-(hydroxymethyl)-N-isobutyl-4-((tetrahydro-2H-pyran-4-yl)methoxy)benzenesulfonamide
- GTPL9661
- SCHEMBL15352875
- LZLBRISQTJVZNP-UHFFFAOYSA-N
- MolPort-044-561-790
- EX-A1179
- ZINC142250256
- AKOS030526564
- CS-5449
- GSK-2981278
- HY-19770
- N-(4-ethylphenyl)-3-(hydroxymethyl)-N-(2-methylpropyl)-4-(oxan-4-ylmethoxy)benzenesulfonamide
- Benzenesulfonamide, N-(4-ethylphenyl)-3-(hydroxymethyl)-N-(2-methylpropyl)-4-((tetrahydro-2H-pyran-4-yl)
- RefChem:144557
- RORgamma Modulator 1
- C25H35NO5S
- orb1303238
- SCHEMBL31239078
- GLXC-10699
- ZIC11021
- BDBM50461084
- s6610
- GSK2981278?
- NCGC00508861-02
- AC-36054
- BS-15442
- DB-213948
- T4050
- F865655
Look up GSK2981278 in the interactive SynDRA portal →